Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 703612, 7 pages
http://dx.doi.org/10.1155/2013/703612
Clinical Study

Post-Dilution on Line Haemodiafiltration with Citrate Dialysate: First Clinical Experience in Chronic Dialysis Patients

1Nephrology and Dialysis Unit, Versilia Hospital, 55034 Lido Camaiore (Lucca), Italy
2Nephrology and Dialysis Unit, Parma Hospital, 43100 Parma, Italy
3Nephrology and Dialysis Unit, Lucca Hospital, 55100 Lucca, Italy
4Nephrology and Dialysis Unit, SM Annunziata Hospital, 50012 Florence, Italy

Received 4 September 2013; Accepted 28 October 2013

Academic Editors: F. Hinoshita and R. Sakai

Copyright © 2013 Vincenzo Panichi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Penne, N. C. van der Weerd, M. A. van den Dorpel et al., “Short-term effects of online hemodiafiltration on phosphate control: a result from the Randomized Controlled Convective Transport study (CONTRAST),” American Journal of Kidney Diseases, vol. 55, no. 1, pp. 77–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Tattersall, A. Martin-Malo, L. Pedrini et al., “EBPG guideline on dialysis strategies,” Nephrology, Dialysis, Transplantation, vol. 22, supplement 2, pp. ii5–ii21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-L. Lin, C.-W. Yang, C.-C. Chiang, C.-T. Chang, and C.-C. Huang, “Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients,” Blood Purification, vol. 19, no. 3, pp. 301–307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Cheung, M. V. Rocco, G. Yan et al., “Serum β-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 546–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. C. Muriel Grooteman, A. Marinus et al., “Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes,” Journal of the American Society of Nephrology, vol. 23, no. 6, pp. 1087–1096, 2012. View at Publisher · View at Google Scholar
  6. W. Lornoy, I. Becaus, J. M. Billiouw, L. Sierens, P. van Malderen, and P. D'Haenens, “On-line haemodiafiltration. Remarkable removal of β2-microglobulin. Long-term clinical observations,” Nephrology Dialysis Transplantation, vol. 15, supplement 1, pp. 49–54, 2000. View at Google Scholar · View at Scopus
  7. H.-J. Guth, S. Gruska, and G. Kraatz, “On-line production of ultrapure substitution fluid reduces TNF-alpha- and IL-6 release in patients on hemodiafiltration therapy,” International Journal of Artificial Organs, vol. 26, no. 3, pp. 181–187, 2003. View at Google Scholar · View at Scopus
  8. B. Canaud, V. Wizemann, F. Pizzarelli et al., “Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy,” Nephrology Dialysis Transplantation, vol. 16, no. 11, pp. 2181–2187, 2001. View at Google Scholar · View at Scopus
  9. J. Carracedo, A. Merino, S. Nogueras et al., “On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2315–2321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Pizzarelli, T. Cerrai, P. Dattolo, and G. Ferro, “On-line haemodiafiltration with and without acetate,” Nephrology Dialysis Transplantation, vol. 21, no. 6, pp. 1648–1651, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ahmad, R. Callan, J. J. Cole, and C. R. Blagg, “Dialysate made from dry chemicals using citric acid increases dialysis dose,” American Journal of Kidney Diseases, vol. 35, no. 3, pp. 493–499, 2000. View at Google Scholar · View at Scopus
  12. E. Bauer, K. Derfler, C. Joukhadar, and W. Druml, “Citrate kinetics in patients receiving long-term hemodialysis therapy,” American Journal of Kidney Diseases, vol. 46, no. 5, pp. 903–907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ahmad, R. Callan, J. Cole, and C. Blagg, “Increased dialyzer reuse with citrate dialysate,” Hemodialysis International, vol. 9, no. 3, pp. 264–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Kozik-Jaromin, V. Nier, U. Heemann, B. Kreymann, and J. Böhler, “Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation,” Nephrology Dialysis Transplantation, vol. 24, no. 7, pp. 2244–2251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Gabutti, B. Lucchini, C. Marone, L. Alberio, and M. Burnier, “Citrate- versus acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes,” BMC Nephrology, vol. 10, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Kossmann, A. Gonzales, R. Callan, and S. Ahmad, “Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 9, pp. 1459–1464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Sands, P. Kotanko, J. H. Segal et al., “Effects of citrate acid concentrate (Citrasate) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial,” Blood Purification, vol. 33, no. 1–3, pp. 199–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Böhler, P. Schollmeyer, B. Dressel, G. Dobos, and W. H. Hörl, “Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation,” Journal of the American Society of Nephrology, vol. 7, no. 2, pp. 234–241, 1996. View at Google Scholar · View at Scopus
  19. J. C. Bos, M. P. C. Grooteman, A. J. van Houte, M. Schoorl, J. van Limbeek, and M. J. Nubé, “Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis,” Nephrology Dialysis Transplantation, vol. 12, no. 7, pp. 1387–1393, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Dhondt, R. Vanholder, C. Tielemans et al., “Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes,” Nephron, vol. 85, no. 4, pp. 334–342, 2000. View at Google Scholar · View at Scopus
  21. L. Gabutti, N. Ferrari, G. Mombelli, F. Keller, and C. Marone, “The favorable effect of regional citrate anticoagulation on interleukin-1β release is dissociated from both coagulation and complement activation,” Journal of Nephrology, vol. 17, no. 6, pp. 819–825, 2004. View at Google Scholar · View at Scopus
  22. M. Gritters, M. P. C. Grooteman, M. Schoorl et al., “Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis,” Nephrology Dialysis Transplantation, vol. 21, no. 1, pp. 153–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Uhlin, I. Fridolin, M. Magnusson, and L.-G. Lindberg, “Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2225–2231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Castellarnau, M. Werner, R. Günthner, and M. Jakob, “Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation,” Kidney International, vol. 78, no. 9, pp. 920–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Bergstrom and B. Wehle, “No change in corrected β2-microglobulin concentration after cuprophane haemodialysis,” The Lancet, vol. 1, no. 8533, pp. 628–629, 1987. View at Google Scholar · View at Scopus
  26. A. J. Bakker, E. C. Boerma, H. Keidel, P. Kingma, and P. H. J. van der Voort, “Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 8, pp. 962–966, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bryland, A. Wieslander, O. Carlsson, T. Hellmark, and G. Godaly, “Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions,” Diabetes & Vascular Disease Research, vol. 9, no. 1, pp. 42–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Noris, M. Todeschini, F. Casiraghi et al., “Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension,” American Journal of Kidney Diseases, vol. 32, no. 1, pp. 115–124, 1998. View at Google Scholar · View at Scopus
  29. M. Todeschini, D. Macconi, N. G. Fernández et al., “Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation,” American Journal of Kidney Diseases, vol. 40, no. 4, pp. 783–793, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. P. Jackson, W. S. Nesbitt, and S. Kulkarni, “Signaling events underlying thrombus formation,” Journal of Thrombosis and Haemostasis, vol. 1, no. 7, pp. 1602–1612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Mariano, L. Tedeschi, M. Morselli, M. Stella, and G. Triolo, “Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients,” Intensive Care Medicine, vol. 36, no. 10, pp. 1735–1743, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Davies and G. Leslie, “Anticoagulation in CRRT: agents and strategies in Australian ICUs,” Australian Critical Care, vol. 20, no. 1, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Kozik-Jaromin, V. Nier, U. Heemann, B. Kreymann, and J. Böhler, “Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation,” Nephrology Dialysis Transplantation, vol. 24, no. 7, pp. 2244–2251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Flanigan, L. Pillsbury, G. Sadewasser, and V. S. Lim, “Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A,” American Journal of Kidney Diseases, vol. 27, no. 4, pp. 519–524, 1996. View at Google Scholar · View at Scopus
  35. P. Faybik, H. Hetz, G. Mitterer et al., “Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system,” Critical Care Medicine, vol. 39, no. 2, pp. 273–279, 2011. View at Publisher · View at Google Scholar · View at Scopus